Global X Genomics & Biotechnology ETF
GNOM
GNOM
58 hedge funds and large institutions have $134M invested in Global X Genomics & Biotechnology ETF in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
58
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26.6M | |
| 2 | +$1.98M | |
| 3 | +$624K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$366K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$325K |
Top Sellers
| 1 | -$9.86M | |
| 2 | -$763K | |
| 3 | -$307K | |
| 4 |
BS
Banco Santander
Madrid,
Spain
|
-$199K |
| 5 |
AWE
Avidian Wealth Enterprises
Houston,
Texas
|
-$150K |